X0508 4 2024-10-18 0001498382 Kintara Therapeutics, Inc. KTRA 0001638744 Ng George K 10500 UNIVERSITY CENTER DRIVE, SUITE 110 TAMPA FL 33612 true false Options (Right to Buy) 2.24 2024-10-18 4 A 0 35780 0 A 2024-10-18 2030-02-06 Common Stock 35780 35780 D Options (Right to Buy) 3.69 2024-10-18 4 A 0 13553 0 A 2024-10-18 2033-01-16 Common Stock 13553 13553 D Options (Right to Buy) 4.14 2024-10-18 4 A 0 13553 0 A 2024-10-18 2034-02-28 Common Stock 13553 13553 D Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the "Merger Agreement"), among the Issuer (fka "Kintara Therapeutics, Inc."), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer ("Merger Sub"), and TuHURA Biosciences, Inc., a Delaware corporation ("Private TuHURA"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the "Merger") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to "TuHURA Biosciences, Inc." /s/ Dan Dearborn as Power of Attorney for George Ng 2024-10-22